Karyopharm Therapeutics, Inc. (KPTI)
6.41
+0.02
(+0.31%)
USD |
NASDAQ |
Dec 10, 12:31
Karyopharm Therapeutics Market Cap: 109.30M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| TG Therapeutics, Inc. | 4.750B |
| Actinium Pharmaceuticals, Inc. | 44.30M |
| Axsome Therapeutics, Inc. | 7.415B |
| Krystal Biotech, Inc. | 6.887B |
| Akebia Therapeutics, Inc. | 420.61M |
Market Cap Related Metrics
| PS Ratio | 0.3840 |
| PEG Ratio | -0.0004 |
| Price | 6.41 |
| Earnings Yield | -227.5% |
| PEGY Ratio | -0.0004 |